Cargando…
Induction of Antibodies and T Cell Responses by a Recombinant Influenza Virus Carrying an HIV-1 TatΔ(51–59) Protein in Mice
Recombinant influenza viruses hold promise as vectors for vaccines to prevent transmission of mucosal pathogens. In this study, we generated a recombinant WSN/TatΔ(51–59) virus in which Tat protein lacking residues 51 to 59 of the basic domain was inserted into the N-terminus of the hemagglutinin (H...
Autores principales: | Garulli, B., Di Mario, G., Stillitano, M. G., Compagnoni, D., Titti, F., Cafaro, A., Ensoli, B., Kawaoka, Y., Castrucci, M. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053076/ https://www.ncbi.nlm.nih.gov/pubmed/24949479 http://dx.doi.org/10.1155/2014/904038 |
Ejemplares similares
-
Immunogenicity of a Recombinant Influenza Virus Bearing Both the CD4+ and CD8+ T Cell Epitopes of Ovalbumin
por: Garulli, Bruno, et al.
Publicado: (2011) -
Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines
por: Titti, Fausto, et al.
Publicado: (2014) -
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease
por: Cafaro, Aurelio, et al.
Publicado: (2019) -
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
por: Ensoli, Barbara, et al.
Publicado: (2021) -
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology
por: Cafaro, Aurelio, et al.
Publicado: (2016)